EQS-Adhoc: Vitruvia Medical AG: Issue of 6.00% Convertibel Bond 2022-2025
|
EQS-Ad-hoc: Vitruvia Medical AG / Key word(s): Financing
Vitruvia Medical AG: Issue of 6.00% Convertibel Bond 2022-2025
26-Nov-2022 / 16:43 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Convertible bond Vitruvia Medical AG ("Private Placement") 6.00% 2022-2025
By resolution of the Board of Directors, Vitruvia Medical AG has resolved to issue a convertible bond ("Private Placement") of CHF 2.2 million at an interest rate of 6.00% p.a. and a term of 3 years. The issue price is set at 100% and the conversion price is EUR 2.50 and is convertible into registered shares of Vitruvia Medical AG.
The funds will be used to finance existing projects (LT technologies GmbH & Co. KG), acquisitions (rebuilding of the investment portfolio) and general corporate financing.
Anglikon, 26 November 2022
Vitruvia Medical Ltd.
Board of directors
26-Nov-2022 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: |
English |
| Company: |
Vitruvia Medical AG |
|
Kesselackerstr. 18 |
|
5611 Anglikon |
|
Switzerland |
| Phone: |
+41 44 915 33 78 |
| E-mail: |
[email protected] |
| Internet: |
www.vitruvia-med.com |
| ISIN: |
CH0461931419 |
| WKN: |
A2PDWF |
| Listed: |
Regulated Unofficial Market in Munich |
| EQS News ID: |
1498163 |
| |
| End of Announcement |
EQS News Service |
1498163 26-Nov-2022 CET/CEST
| 
Vitruvia Medical AG CH0461931419